DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Negri FV, Dal Bello B, Porta C. et al.
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment.
Liver Int 2015;
35 (08) 2001-2008
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.